Arch Therapeutics (ARTH) News Today Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsShort InterestBuy This Stock ARTH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Arch Therapeutics Inc. (ARTH) Product Pipeline Analysis, 2025 UpdateAugust 9, 2025 | finance.yahoo.comArch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)October 1, 2024 | globenewswire.comChicago biotech-focused VC firm Arch Venture Partners closes $3 billion fundSeptember 27, 2024 | bizjournals.comArch Therapeutics, Inc. (ARTH)August 21, 2024 | finance.yahoo.comArch Biopartners' Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug ToxinsAugust 2, 2024 | tmcnet.comArch Therapeutics to Present AC5® Advanced Wound System at the 2024 Symposium on Advanced Wound Care Spring Meeting (SAWC Spring)May 6, 2024 | globenewswire.comArch Therapeutics Secures $750K Prepayment for StockFebruary 8, 2024 | msn.comArch Therapeutics Inc ARTHJanuary 6, 2024 | morningstar.comMAre Medical Stocks Lagging Arch Therapeutics (ARTH) This Year?November 23, 2023 | msn.comArch Therapeutics, Inc.: Arch Therapeutics Provides Year End Operational UpdateNovember 9, 2023 | finanznachrichten.deArch Therapeutics Provides Year End Operational UpdateNovember 9, 2023 | finance.yahoo.comArch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)November 2, 2023 | finance.yahoo.comArch Therapeutics Provides AC5® Commercialization UpdateSeptember 13, 2023 | finance.yahoo.comArch Therapeutics, Inc.: Arch Therapeutics Completes Financing as Bridge to UplistingSeptember 8, 2023 | finanznachrichten.deArch Therapeutics Completes Financing as Bridge to UplistingSeptember 7, 2023 | finance.yahoo.comDr. Arth PatelJuly 8, 2023 | health.usnews.comDouble ArchJune 13, 2023 | travel.usnews.comArch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)April 25, 2023 | finance.yahoo.comDedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In EffectApril 5, 2023 | finance.yahoo.comArch Therapeutics Inc (ARTHD)March 20, 2023 | investing.comArch Therapeutics’ AC5® Advanced Wound System Receives Dedicated HCPCS Billing Code from The Centers for Medicare & Medicaid ServicesMarch 9, 2023 | finance.yahoo.comArch Therapeutics Announces Addition of Contract Sales Force to Advance Commercialization of AC5® Advanced Wound System in Government FacilitiesMarch 7, 2023 | finance.yahoo.comArch Therapeutics Inc Stock (OTC:ARTHD), Earnings Estimates, EPS, and RevenueFebruary 23, 2023 | benzinga.comWound products developer Arch Therapeutics files for uplisting, $35M offering (update)January 24, 2023 | msn.comArch Therapeutics, Inc.: Arch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National ExchangeJanuary 18, 2023 | finanznachrichten.deArch Therapeutics Announces Formation of Medical Advisory Board to Advance Commercialization of AC5® Advanced Wound SystemJanuary 18, 2023 | finance.yahoo.comArch Announces One-for-Two-Hundred Reverse Stock Split in Connection with Application for Uplisting to a National ExchangeJanuary 17, 2023 | finance.yahoo.comThe Centers for Medicare & Medicaid Services Makes Preliminary Recommendation to Establish New HCPCS Billing Code Dedicated to Arch Therapeutics’ AC5® Advanced Wound SystemDecember 5, 2022 | finance.yahoo.comARTH Arch Therapeutics, Inc.October 20, 2022 | seekingalpha.comKey Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) FallOctober 18, 2022 | yahoo.comArch Therapeutics’ AC5® Advanced Wound System to be Presented with Honors at 2022 Symposium on Advanced Wound Care (SAWC) FallOctober 11, 2022 | finance.yahoo.comArch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support ProgramSeptember 23, 2022 | finance.yahoo.comArch Therapeutics Announces Intent to Uplist from OTC to a National ExchangeSeptember 16, 2022 | finance.yahoo.comArch Therapeutics Launches Multi-Site Clinical Study for AC5® Advanced Wound SystemSeptember 7, 2022 | finance.yahoo.comArch Therapeutics (OTC:ARTH), Short Interest ReportJuly 13, 2022 | benzinga.comArch Therapeutics Raises Approximately $3.5 Million in Convertible Note FinancingJuly 7, 2022 | finance.yahoo.comArch Therapeutics Provides Update on Reimbursement Strategy in Additional Selling ChannelJune 22, 2022 | finance.yahoo.comArch Therapeutics’ Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC SpringMay 9, 2022 | finance.yahoo.comArch Therapeutics' Experts in Wound Care Interview Showcases AC5 Self-Assembling Peptide Technology During Live Session at SAWC SpringMay 9, 2022 | benzinga.comRenowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) SpringApril 13, 2022 | finance.yahoo.comArch Therapeutics’ AC5® Advanced Wound System to be Presented at 2022 Symposium on Advanced Wound Care (SAWC) SpringApril 4, 2022 | finance.yahoo.comArch Therapeutics Partners with Centurion Therapeutics to Expand Access to AC5® Advanced Wound SystemMarch 14, 2022 | finance.yahoo.comClinical Evaluation Finds Arch Therapeutics’ AC5® Advanced Wound System Effective in Healing Complex Chronic Wounds in Patients with Previously Unsuccessful Treatments and Significant ComorbiditiesJanuary 6, 2022 | finance.yahoo.comArch Therapeutics Announces Appointment of Guy Fish to the BoardJanuary 4, 2022 | finance.yahoo.comArch Therapeutics Granted Federal Supply Schedule and General Supply Administration Contracts for AC5® Advanced Wound SystemDecember 13, 2021 | finance.yahoo.comArch Therapeutics Adds Key Opinion Leader Interview on Diabetic Foot Ulcers to the Experts in Wound Care ProgramDecember 1, 2021 | finance.yahoo.comArch Therapeutics Presents AC5® Advanced Wound System During Innovation Spotlight at 2021 Symposium on Advanced Wound Care (SAWC)November 1, 2021 | finance.yahoo.comArch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) FallOctober 25, 2021 | finance.yahoo.comArch Therapeutics Launches Experts in Wound Care ProgramOctober 18, 2021 | finance.yahoo.comArch Therapeutics Provides Corporate UpdateOctober 13, 2021 | finance.yahoo.com Get Arch Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARTH Media Mentions By Week ARTH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARTH News Sentiment▼0.001.11▲Average Medical News Sentiment ARTH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARTH Articles This Week▼00▲ARTH Articles Average Week Get the Latest News and Ratings for ARTH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arch Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies UAHC News Today AEMD News Today GCTK News Today LGMK News Today BLAC News Today USAQ News Today BJDX News Today VTAK News Today NAOV News Today BBLG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ARTH) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arch Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arch Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
